IkT-148009 is a new approach to altering the course of Parkinson’s Disease.  The 201 Clinical Trial will explore whether IkT-148009 can slow or halt disease progression, and will also evaluate whether IkT-148009 can partially or completely restore lost function for Parkinson's patients. If you have been diagnosed with Parkinson’s disease and do not take any Parkinson’s medications, you may be eligible to participate in this ground-breaking study. 

Learn more at www.the201trial.com